Trillium Therapeutics Inc. (TRIL) Tumbled -5.68% or -0.02 To Price $0.41 On Thursday


Trillium Therapeutics Inc. (TRIL) tumbled -5.68% or -0.02 to $0.41. It is approximately 979394 shares traded, which is 86.43% compare to the average total volume 1.13 million. The market cap of TRIL is $10.79 million. The year to date change is -83.26%. The 52 week price range is from $0.4 to $7.0. Price of TRIL have changed -34.01% during last week. It have changed -29.84% over last month, -40.66% over last 3 months, -84.52% over last 6 months and -92.78% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TRIL is 0.63. It is 53.66% above current price. The 200-day Moving Averages for TRIL is 2.57. It is 526.83% above current price. The 52-week High is 7.0. It is 1607.32% from the current price. The 52-week Low is 0.4. It is -2.44% from current price.

There are some statistics of TRIL. It is has market cap $10.79 million. The share outstanding is 26.29 million. The average volume is 1.13 million. The percent of top 15 Institution holding is 27.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TRIL is -408.54%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TRIL is -60.08%.


Tags:

Share this post